Upgrade

BlackRock Health Sciences Trust

BMEZ

Last
$16.52
Day
+1.6%
1y
+8.8%
5y
-40.2%
52w
-5.7%
SPY YTD
+13.3%
XLF
-1.3%
Earnings
—
EMA 21
16.55
EMA 50
16.36
EMA 200
15.46
20d high
-4.6%
5y high
-42.9%
5y range
23th
United States

Positions held

Your positions

BMEZ isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
4
Hold
watch
Signal
Neutral
Target
$17.08
Stop
$15.85
Stop distance
4.1%
Target vs last
+3.4%

Bull / bear case

Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-08.

Bull case
  • The asset management industry is experiencing a shift towards healthcare investments, which could benefit BMEZ given its focus on health sciences.
  • BMEZ has a market capitalization of approximately $1.02 billion, indicating a solid presence in the financial services sector.
  • The trailing P/E ratio of 4.83 suggests that BMEZ may be undervalued compared to its peers.
Bear case
  • The lack of revenue and profit margins raises concerns about the fund's operational efficiency and sustainability.
  • BMEZ's score is neutral at 5.00, indicating no strong buy or sell signals currently.
  • The technical indicators show a bearish trend with MACD down and RSI at 45, suggesting potential downward pressure.

Fundamentals

Market cap$1.02BEnterprise value—Trailing P/E4.80Forward P/E—
PEG—Price / book—Beta—Dividend yield8.12%
Revenue growth—Earnings growth—Gross margin0.0%Operating margin0.0%
Profit margin0.0%ROE—ROA—Debt / equity—
Current ratio—Free cash flow—Analyst recommendationnoneMean target—
52w high$17.2552w low$13.70

Quarterly

No data yet.

Yearly (6y)

2024202320222021
Revenue————
Op margin————
Net income————
Gross margin————
Gross profit————
Operating income————
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

BMEZ · daily-2.9% over 14 sessions
Close EMA21 EMA50 EMA200
16.0516.3116.5716.8317.092026-092026-092026-092026-092026-102026-102026-10